Ultrasound-mediated blood-brain barrier disruption for targeted drug delivery in the central nervous system

Advanced Drug Delivery Reviews

Volumn 72, Issue , 2014, Pages 94-109

  Aryal, Muna ^a,b   Arvanitis, Costas D ^b   Alexander, Phillip M ^b,c   McDannold, Nathan ^b  

^a BOSTON COLLEGE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BRASENOSE COLLEGE   (United Kingdom)

Author keywords

Brain; Drug delivery; Microbubbles; Ultrasound

Indexed keywords

BRAIN; DRUG DELIVERY; NEUROPHYSIOLOGY; NONINVASIVE MEDICAL PROCEDURES; ULTRASONICS;

BLOOD-BRAIN BARRIER; CENTRAL NERVOUS SYSTEMS; CLINICAL TRANSLATION; DELIVERY TECHNIQUES; FOCUSED ULTRASOUND; MICROBUBBLES; NONINVASIVE METHODS; TARGETED DRUG DELIVERY;

ULTRASONIC APPLICATIONS;

ANIMAL; BLOOD BRAIN BARRIER; DRUG DELIVERY SYSTEM; HUMAN; METABOLISM; PROCEDURES; ULTRASOUND; ULTRASOUND THERAPY;

ANIMALS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HUMANS; ULTRASONIC THERAPY; ULTRASONICS;

EID: 84901589724     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2014.01.008     Document Type: Review

References (194)

1. Neuwelt E.A., Bauer B., Fahlke C., Fricker G., Iadecola C., Janigro D., Leybaert L., Molnar Z., O'Donnell M.E., Povlishock J.T., Saunders N.R., Sharp F., Stanimirovic D., Watts R.J., Drewes L.R. Engaging neuroscience to advance translational research in brain barrier biology. Nat. Rev. Neurosci. 2011, 12:169-182.
2. Abbott N.J., Romero I.A. Transporting therapeutics across the blood-brain barrier. Mol. Med. Today 1996, 2:106-113.
3. Pardridge W.M. Molecular biology of the blood-brain barrier. Mol. Biotechnol. 2005, 30:57-70.
4. Eichler A.F., Chung E., Kodack D.P., Loeffler J.S., Fukumura D., Jain R.K. The biology of brain metastases-translation to new therapies. Nat. Rev. Clin. Oncol. 2011, 8:344-356.
5. Minniti G., Amelio D., Amichetti M., Salvati M., Muni R., Bozzao A., Lanzetta G., Scarpino S., Arcella A., Enrici R.M. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide. Radiother. Oncol. 2010, 97:377-381.
6. Dobelbower M.C., Burnett Iii O.L., Nordal R.A., Nabors L.B., Markert J.M., Hyatt M.D., Fiveash J.B. Patterns of failure for glioblastoma multiforme following concurrent radiation and temozolomide. J. Med. Imaging Radiat. Oncol. 2011, 55:77-81.
7. Chamberlain M.C. Radiographic patterns of relapse in glioblastoma. J. Neurooncol. 2011, 101:319-323.
8. Fukumura D., Jain R.K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J. Cell. Biochem. 2007, 101:937-949.
9. Regina A., Demeule M., Laplante A., Jodoin J., Dagenais C., Berthelet F., Moghrabi A., Beliveau R. Multidrug resistance in brain tumors: roles of the blood-brain barrier. Cancer Metastasis Rev. 2001, 20:13-25.
10. Lockman P.R., Mittapalli R.K., Taskar K.S., Rudraraju V., Gril B., Bohn K.A., Adkins C.E., Roberts A., Thorsheim H.R., Gaasch J.A., Huang S., Palmieri D., Steeg P.S., Smith Q.R. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clin. Cancer Res. 2010, 16:5664-5678.
11. Groothuis D.R. The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neuro Oncol. 2000, 2:45-59.
12. Pardridge W.M. Blood-brain barrier delivery. Drug Discov. Today 2007, 12:54-61.
13. Blumling Iii J.P., Silva G.A. Targeting the brain: advances in drug delivery. Curr. Pharm. Biotechnol. 2012, 13:2417-2426.
14. Tomita T. Interstitial chemotherapy for brain tumors: review. J. Neurooncol. 1991, 10:57-74.
15. Bobo R.H., Laske D.W., Akbasak A., Morrison P.F., Dedrick R.L., Oldfield E.H. Convection-enhanced delivery of macromolecules in the brain. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:2076-2080.
16. Guerin C., Olivi A., Weingart J.D., Lawson H.C., Brem H. Recent advances in brain tumor therapy: local intracerebral drug delivery by polymers. Invest. New Drugs 2004, 22:27-37.
17. Brem H., Gabikian P. Biodegradable polymer implants to treat brain tumors. J. Control. Release 2001, 74:63-67.
18. Fung L.K., Shin M., Tyler B., Brem H., Saltzman W.M. Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharm. Res. 1996, 13:671-682.
19. Voges J., Reszka R., Gossmann A., Dittmar C., Richter R., Garlip G., Kracht L., Coenen H.H., Sturm V., Wienhard K., Heiss W.D., Jacobs A.H. Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma. Ann. Neurol. 2003, 54:479-487.
20. Fleischhack G., Jaehde U., Bode U. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. Clin. Pharmacokinet. 2005, 44:1-31.
21. Illum L. Nasal drug delivery-possibilities, problems and solutions. J. Control. Release 2003, 87:187-198.
22. Illum L. Nasal drug delivery: new developments and strategies. Drug Discov. Today 2002, 7:1184-1189.
23. Ugwoke M.I., Agu R.U., Verbeke N., Kinget R. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv. Drug Deliv. Rev. 2005, 57:1640-1665.
24. Pires A., Fortuna A., Alves G., Falcao A. Intranasal drug delivery: how, why and what for?. J. Pharm. Pharm. Sci. 2009, 12:288-311.
25. Oldendorf W.H., Hyman S., Braun L., Oldendorf S.Z. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 1972, 178:984-986.
26. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
27. Zhang E.Y., Knipp G.T., Ekins S., Swaan P.W. Structural biology and function of solute transporters: implications for identifying and designing substrates. Drug Metab. Rev. 2002, 34:709-750.
28. Pardridge W.M. Blood-brain barrier drug targeting: the future of brain drug development. Mol. Interv. 2003, 3:90-105. (51).
29. Pardridge W.M. Drug targeting to the brain. Pharm. Res. 2007, 24:1733-1744.
30. Blasi P., Giovagnoli S., Schoubben A., Ricci M., Rossi C. Solid lipid nanoparticles for targeted brain drug delivery. Adv. Drug Deliv. Rev. 2007, 59:454-477.
31. Olivier J.C. Drug transport to brain with targeted nanoparticles. NeuroRx 2005, 2:108-119.
32. Schnyder A., Huwyler J. Drug transport to brain with targeted liposomes. NeuroRx 2005, 2:99-107.
33. Broadwell R.D., Balin B.J., Salcman M. Transcytotic pathway for blood-borne protein through the blood-brain barrier. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:632-636.
34. Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 1996, 12:575-625.
35. Mukherjee S., Ghosh R.N., Maxfield F.R. Endocytosis. Physiol. Rev. 1997, 77:759-803.
36. Rapoport S.I. Effect of concentrated solutions on blood-brain barrier. Am. J. Physiol. 1970, 219:270-274.
37. Rapoport S.I. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert. Opin. Investig. Drugs 2001, 10:1809-1818.
38. Kroll R.A., Neuwelt E.A. Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means. Neurosurgery 1998, 42:1083-1099.
39. Bellavance M.A., Blanchette M., Fortin D. Recent advances in blood-brain barrier disruption as a CNS delivery strategy. AAPS J. 2008, 10:166-177.
40. Doolittle N.D., Miner M.E., Hall W.A., Siegal T., Jerome E., Osztie E., McAllister L.D., Bubalo J.S., Kraemer D.F., Fortin D., Nixon R., Muldoon L.L., Neuwelt E.A. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000, 88:637-647.
41. Hall W.A., Doolittle N.D., Daman M., Bruns P.K., Muldoon L., Fortin D., Neuwelt E.A. Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas. J. Neurooncol. 2006, 77:279-284.
42. Jahnke K., Kraemer D.F., Knight K.R., Fortin D., Bell S., Doolittle N.D., Muldoon L.L., Neuwelt E.A. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system. Cancer 2008, 112:581-588.
43. Angelov L., Doolittle N.D., Kraemer D.F., Siegal T., Barnett G.H., Peereboom D.M., Stevens G., McGregor J., Jahnke K., Lacy C.A., Hedrick N.A., Shalom E., Ference S., Bell S., Sorenson L., Tyson R.M., Haluska M., Neuwelt E.A. Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience. J. Clin. Oncol. 2009, 27:3503-3509.
44. Boockvar J.A., Tsiouris A.J., Hofstetter C.P., Kovanlikaya I., Fralin S., Kesavabhotla K., Seedial S.M., Pannullo S.C., Schwartz T.H., Stieg P., Zimmerman R.D., Knopman J., Scheff R.J., Christos P., Vallabhajosula S., Riina H.A. Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article. J. Neurosurg. 2011, 114:624-632.
45. Guillaume D.J., Doolittle N.D., Gahramanov S., Hedrick N.A., Delashaw J.B., Neuwelt E.A. Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study. Neurosurgery 2010, 66:48-58.
46. Inamura T., Nomura T., Ikezaki K., Fukui M., Pollinger G., Black K.L. Intracarotid histamine infusion increases blood tumour permeability in RG2 glioma. Neurol. Res. 1994, 16:125-128.
47. Gutman M., Laufer R., Eisenthal A., Goldman G., Ravid A., Inbar M., Klausner J.M. Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthiourea. Cancer Immunol. Immunother. 1996, 43:240-244.
48. Black K.L., Chio C.C. Increased opening of blood-tumour barrier by leukotriene C4 is dependent on size of molecules. Neurol. Res. 1992, 14:402-404.
49. de Vries H.E., Blom-Roosemalen M.C., van Oosten M., de Boer A.G., van Berkel T.J., Breimer D.D., Kuiper J. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J. Neuroimmunol. 1996, 64:37-43.
50. Lynn J.G., Putnam T.J. Histology of cerebral lesions produced by focused ultrasound. Am. J. Pathol. 1944, 20:637-652.
51. Fry W.J., Fry F.J. Fundamental neurological research and human neurosurgery using intense ultrasound. IRE Trans. Med. Electron. 1960, ME-7:166-181.
52. Ballantine H.T., Bell E., Manlapaz J. Progress and problems in the neurological applications of focused ultrasound. J. Neurosurg. 1960, 17:858-876.
53. Lele P.P. Effects of ultrasound on "solid" mammalian tissues and tumors in vivo. Ultrasound: Medical Applications, Biological Effects and Hazard Potential 1987, 275-306. Plenum Pub. Corp, New York. M.H. Repacholi, M. Grondolfo, A. Rindi (Eds.).
54. Meyers R., Fry W.J., Fry F.J., Dreyer L.L., Shultz D.F., Noyes R.F. Early experiences with ultrasonic irradiation of the pallidfugal and nigral complexes in hyperkinetic and hypertonic disorders. J. Neurosurg. 1959, 16:32-54.
55. Heimburger R.F. Ultrasound augmentation of central nervous system tumor therapy. Indiana Med. 1985, 78:469-476.
56. Hynynen K., McDannold N. MRI guided and monitored focused ultrasound thermal ablation methods: a review of progress. Int. J. Hyperthermia 2004, 20:725-737.
57. Clement G.T., Hynynen K. A non-invasive method for focusing ultrasound through the human skull. Phys. Med. Biol. 2002, 47:1219-1236.
58. Aubry J.F., Tanter M., Pernot M., Thomas J.L., Fink M. Experimental demonstration of noninvasive transskull adaptive focusing based on prior computed tomography scans. J. Acoust. Soc. Am. 2003, 113:84-93.
59. Ishihara Y., Calderon A., Watanabe H., Okamoto K., Suzuki Y., Kuroda K. A precise and fast temperature mapping using water proton chemical shift. Magn. Reson. Med. 1995, 34:814-823.
60. McDannold N., Clement G.T., Black P., Jolesz F., Hynynen K. Transcranial magnetic resonance imaging-guided focused ultrasound surgery of brain tumors: initial findings in 3 patients. Neurosurgery 2010, 66:323-332.
61. Lipsman N., Schwartz M.L., Huang Y., Lee L., Sankar T., Chapman M., Hynynen K., Lozano A.M. MR-guided focused ultrasound thalamotomy for essential tremor: a proof-of-concept study. Lancet Neurol. 2013, 12:462-468.
62. Elias W.J., Huss D., Voss T., Loomba J., Khaled M., Zadicario E., Frysinger R.C., Sperling S.A., Wylie S., Monteith S.J., Druzgal J., Shah B.B., Harrison M., Wintermark M. A pilot study of focused ultrasound thalamotomy for essential tremor. N. Engl. J. Med. 2013, 369:640-648.
63. Martin E., Jeanmonod D., Morel A., Zadicario E., Werner B. High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann. Neurol. 2009, 66:858-861.
64. Nyborg W.L., Carson P.L., Carstensen E.L., Dunn F., Miller D.L., Miller M.W., Thompson H.E., Ziskin M.C., Apfel R.E., Church C.C., Crum L.A. Exposure Criteria for Medical Diagnostic Ultrasound: II. Criteria Based on All Known Mechanisms (NCRP Report No. 140) 2002, National Council on Radiation Protection and Measurements, Bethesda, Maryland.
65. Leighton T.G. The Acoustic Bubble 1994, Academic Press Limited, San Diego, CA.
66. Dayton P., Klibanov A., Brandenburger G., Ferrara K. Acoustic radiation force in vivo: a mechanism to assist targeting of microbubbles. Ultrasound Med. Biol. 1999, 25:1195-1201.
67. Miller D.L. Particle gathering and microstreaming near ultrasonically activated gas-filled micropores. J. Acoust. Soc. Am. 1988, 84:1378-1387.
68. Edmonds P.D., Sancier K.M. Evidence for free radical production by ultrasonic cavitation in biological media. Ultrasound Med. Biol. 1983, 9:635-639.
69. Flynn H.G. Generation of transient cavities in liquids by microsecond pulses of ultrasound. J. Acoust. Soc. Am. 1982, 72:1926-1932.
70. Apfel R.E. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br. J. Cancer Suppl. 1982, 45:140-146.
71. Bakay L., Hueter T.F., Ballantine H.T., Sosa D. Ultrasonically produced changes in the blood-brain barrier. Arch. Neurol. 1956, 76:457-467.
72. Vykhodtseva N. Effects of high intensity pulsed ultrasound on brain tissues. The 5th International Symposium on Ultrasound in Biol Med. Puschino, Russia 1981, 95-97.
73. Patrick J.T., Nolting M.N., Goss S.A., Dines K.A., Clendenon J.L., Rea M.A., Heimburger R.F. Ultrasound and the blood-brain barrier. Adv. Exp. Med. Biol. 1990, 267:369-381.
74. Vykhodtseva N.I., Hynynen K., Damianou C. Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med. Biol. 1995, 21:969-979.
75. Mesiwala A.H., Farrell L., Wenzel H.J., Silbergeld D.L., Crum L.A., Winn H.R., Mourad P.D. High-intensity focused ultrasound selectively disrupts the blood-brain barrier in vivo. Ultrasound Med. Biol. 2002, 28:389-400.
76. McDannold N., Vykhodtseva N., Jolesz F.A., Hynynen K. MRI investigation of the threshold for thermally induced blood-brain barrier disruption and brain tissue damage in the rabbit brain. Magn. Reson. Med. 2004, 51:913-923.
77. Hynynen K., McDannold N., Vykhodtseva N., Jolesz F.A. Noninvasive MR imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 2001, 220:640-646.
78. Sheikov N., McDannold N., Vykhodtseva N., Jolesz F., Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med. Biol. 2004, 30:979-989.
79. McDannold N., Arvanitis C.D., Vykhodtseva N., Livingstone M.S. Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res. 2012, 72:3652-3663.
80. Marquet F., Tung Y.S., Teichert T., Ferrera V.P., Konofagou E.E. Noninvasive, transient and selective blood-brain barrier opening in non-human primates in vivo. PLoS One 2011, 6:e22598.
81. O'Reilly M.A., Huang Y., Hynynen K. The impact of standing wave effects on transcranial focused ultrasound disruption of the blood-brain barrier in a rat model. Phys. Med. Biol. 2010, 55:5251-5267.
82. Hynynen K., McDannold N., Sheikov N.A., Jolesz F.A., Vykhodtseva N. Local and reversible blood-brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 2005, 24:12-20.
83. Treat L.H., McDannold N., Zhang Y., Vykhodtseva N., Hynynen K. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int. J. Cancer 2007, 121:901-907.
84. Chopra R., Vykhodtseva N., Hynynen K. Influence of exposure time and pressure amplitude on blood-brain-barrier opening using transcranial ultrasound exposures. ACS Chem. Neurosci. 2010, 1:391-398.
85. McDannold N., Vykhodtseva N., Hynynen K. Blood-brain barrier disruption induced by focused ultrasound and circulating preformed microbubbles appears to be characterized by the mechanical index. Ultrasound Med. Biol. 2008, 34:834-840.
86. McDannold N., Vykhodtseva N., Hynynen K. Effects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruption. Ultrasound Med. Biol. 2008, 34:930-937.
87. Choi J.J., Feshitan J.A., Baseri B., Wang S., Tung Y.S., Borden M.A., Konofagou E.E. Microbubble-size dependence of focused ultrasound-induced blood-brain barrier opening in mice in vivo. IEEE Trans. Biomed. Eng. 2010, 57:145-154.
88. Vlachos F., Tung Y.S., Konofagou E. Permeability dependence study of the focused ultrasound-induced blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI. Magn. Reson. Med. 2011, 66:821-830.
89. Samiotaki G., Vlachos F., Tung Y.S., Konofagou E.E. A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood-brain barrier opening reversibility in vivo using MRI. Magn. Reson. Med. 2012, 67:769-777.
90. Choi J.J., Selert K., Gao Z., Samiotaki G., Baseri B., Konofagou E.E. Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies. J. Cereb. Blood Flow Metab. 2011, 31:725-737.
91. Choi J.J., Selert K., Vlachos F., Wong A., Konofagou E.E. Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:16539-16544.
92. Bing K.F., Howles G.P., Qi Y., Palmeri M.L., Nightingale K.R. Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and Definity in mice. Ultrasound Med. Biol. 2009, 35:1298-1308.
93. Yang F.Y., Fu W.M., Yang R.S., Liou H.C., Kang K.H., Lin W.L. Quantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med. Biol. 2007, 33:1421-1427.
94. Weng J.C., Wu S.K., Lin W.L., Tseng W.Y. Detecting blood-brain barrier disruption within minimal hemorrhage following transcranial focused ultrasound: a correlation study with contrast-enhanced MRI. Magn. Reson. Med. 2011, 65:802-811.
95. Weng J.C., Wu S.K., Yang F.Y., Lin W.L., Tseng W.Y. Pulse sequence and timing of contrast-enhanced MRI for assessing blood-brain barrier disruption after transcranial focused ultrasound in the presence of hemorrhage. J. Magn. Reson. Imaging 2010, 31:1323-1330.
96. Park J., Zhang Y., Vykhodtseva N., Jolesz F.A., McDannold N.J. The kinetics of blood brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. J. Control. Release 2012, 162:134-142.
97. Yang F.Y., Lin Y.S., Kang K.H., Chao T.K. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation. J. Control. Release 2011, 150:111-116.
98. O'Reilly M.A., Waspe A.C., Ganguly M., Hynynen K. Focused-ultrasound disruption of the blood-brain barrier using closely-timed short pulses: influence of sonication parameters and injection rate. Ultrasound Med. Biol. 2011, 37:587-594.
99. McDannold N., Zhang Y., Vykhodtseva N. Blood-brain barrier disruption and vascular damage induced by ultrasound bursts combined with microbubbles can be influenced by choice of anesthesia protocol. Ultrasound Med. Biol. 2011, 37:1259-1270.
100. Wang J.E., Liu Y.H., Liu L.B., Xia C.Y., Zhang Z., Xue Y.X. Effects of combining low frequency ultrasound irradiation with papaverine on the permeability of the blood-tumor barrier. J. Neurooncol. 2010, 102(2):213-224.
101. Zhang Z., Xia C., Xue Y., Liu Y. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction. J. Neurosci. Res. 2009, 87:2282-2289.
102. Zhang Z., Xue Y., Liu Y., Shang X. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma. Neurosci. Lett. 2010, 481:21-25.
103. Goertz D.E., Wright C., Hynynen K. Contrast agent kinetics in the rabbit brain during exposure to therapeutic ultrasound. Ultrasound Med. Biol. 2010, 36:916-924.
104. Liu H.L., Pan C.H., Ting C.Y., Hsiao M.J. Opening of the blood-brain barrier by low-frequency (28-kHz) ultrasound: a novel pinhole-assisted mechanical scanning device. Ultrasound Med. Biol. 2010, 36:325-335.
105. McDannold N., Vykhodtseva N., Hynynen K. Targeted disruption of the blood-brain barrier with focused ultrasound: association with cavitation activity. Phys. Med. Biol. 2006, 51:793-807.
106. Tung Y.S., Vlachos F., Choi J.J., Deffieux T., Selert K., Konofagou E.E. In vivo transcranial cavitation threshold detection during ultrasound-induced blood-brain barrier opening in mice. Phys. Med. Biol. 2010, 55:6141-6155.
107. Arvanitis C.D., Livingstone M.S., Vykhodtseva N., McDannold N. Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One 2012, 7:e45783.
108. Deng C.X., Sieling F., Pan H., Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med. Biol. 2004, 30:519-526.
109. Sheikov N., McDannold N., Sharma S., Hynynen K. Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med. Biol. 2008, 34:1093-1104.
110. Sheikov N., McDannold N., Jolesz F., Zhang Y.Z., Tam K., Hynynen K. Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood-brain barrier. Ultrasound Med. Biol. 2006, 32:1399-1409.
111. Raymond S.B., Skoch J., Hynynen K., Bacskai B.J. Multiphoton imaging of ultrasound/Optison mediated cerebrovascular effects in vivo. J. Cereb. Blood Flow Metab. 2007, 27:393-403.
112. Cho E.E., Drazic J., Ganguly M., Stefanovic B., Hynynen K. Two-photon fluorescence microscopy study of cerebrovascular dynamics in ultrasound-induced blood-brain barrier opening. J. Cereb. Blood Flow Metab. 2011, 31:1852-1862.
113. Chen H., Kreider W., Brayman A.A., Bailey M.R., Matula T.J. Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys. Rev. Lett. 2011, 106:034301.
114. Sassaroli E., Hynynen K. Resonance frequency of microbubbles in small blood vessels: a numerical study. Phys. Med. Biol. 2005, 50:5293-5305.
115. Marty B., Larrat B., Van Landeghem M., Robic C., Robert P., Port M., Le Bihan D., Pernot M., Tanter M., Lethimonnier F., Meriaux S. Dynamic study of blood-brain barrier closure after its disruption using ultrasound: a quantitative analysis. J. Cereb. Blood Flow Metab. 2012, 32:1948-1958.
116. Howles G.P., Bing K.F., Qi Y., Rosenzweig S.J., Nightingale K.R., Johnson G.A. Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood-brain barrier with ultrasound. Magn. Reson. Med. 2010, 64:995-1004.
117. Baseri B., Choi J.J., Tung Y.S., Konofagou E.E. Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and Definity microbubbles: a short-term study. Ultrasound Med. Biol. 2010, 36:1445-1459.
118. McDannold N., Vykhodtseva N., Raymond S., Jolesz F.A., Hynynen K. MRI-guided targeted blood-brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med. Biol. 2005, 31:1527-1537.
119. Liu H.L., Wai Y.Y., Chen W.S., Chen J.C., Hsu P.H., Wu X.Y., Huang W.C., Yen T.C., Wang J.J. Hemorrhage detection during focused-ultrasound induced blood-brain-barrier opening by using susceptibility-weighted magnetic resonance imaging. Ultrasound Med. Biol. 2008, 34:598-606.
120. Hynynen K., McDannold N., Vykhodtseva N., Raymond S., Weissleder R., Jolesz F.A., Sheikov N. Focal disruption of the blood-brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J. Neurosurg. 2006, 105:445-454.
121. Liu H.L., Wai Y.Y., Hsu P.H., Lyu L.A., Wu J.S., Shen C.R., Chen J.C., Yen T.C., Wang J.J. In vivo assessment of macrophage CNS infiltration during disruption of the blood-brain barrier with focused ultrasound: a magnetic resonance imaging study. J. Cereb. Blood Flow Metab. 2010, 30:674.
122. Shang X., Wang P., Liu Y., Zhang Z., Xue Y. Mechanism of low-frequency ultrasound in opening blood-tumor barrier by tight junction. J. Mol. Neurosci. 2011, 43:364-369.
123. Alonso A., Reinz E., Jenne J.W., Fatar M., Schmidt-Glenewinkel H., Hennerici M.G., Meairs S. Reorganization of gap junctions after focused ultrasound blood-brain barrier opening in the rat brain. J. Cereb. Blood Flow Metab. 2010, 30:1394-1402.
124. Deng J., Huang Q., Wang F., Liu Y., Wang Z., Wang Z., Zhang Q., Lei B., Cheng Y. The role of caveolin-1 in blood-brain barrier disruption induced by focused ultrasound combined with microbubbles. J. Mol. Neurosci. 2012, 46:677-687.
125. Xia C.Y., Liu Y.H., Wang P., Xue Y.X. Low-frequency ultrasound irradiation increases blood-tumor barrier permeability by transcellular pathway in a rat glioma model. J. Mol. Neurosci. 2012, 48(1):281-290.
126. Shajahan A.N., Tiruppathi C., Smrcka A.V., Malik A.B., Minshall R.D. Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells. J. Biol. Chem. 2004, 279:48055-48062.
127. Jalali S., Huang Y., Dumont D.J., Hynynen K. Focused ultrasound-mediated BBB disruption is associated with an increase in activation of Akt: experimental study in rats. BMC Neurol. 2010, 10:114.
128. Zhao H., Sapolsky R.M., Steinberg G.K. Phosphoinositide-3-kinase/Akt survival signal pathways are implicated in neuronal survival after stroke. Mol. Neurobiol. 2006, 34:249-270.
129. Nath R., McGinnis K., Dutta S., Shivers B., Wang K.K. Inhibition of p38 kinase mimics survival signal-linked protection against apoptosis in rat cerebellar granule neurons. Cell. Mol. Biol. Lett. 2001, 6:173-184.
130. Harada J., Sugimoto M. An inhibitor of p38 and JNK MAP kinases prevents activation of caspase and apoptosis of cultured cerebellar granule neurons. Jpn. J. Pharmacol. 1999, 79:369-378.
131. Alonso A., Reinz E., Fatar M., Jenne J., Hennerici M.G., Meairs S. Neurons but not glial cells overexpress ubiquitin in the rat brain following focused ultrasound-induced opening of the blood-brain barrier. Neuroscience 2010, 169:116-124.
132. 2+ concentration in brain microvascular endothelial cells in vitro by acoustic cavitation. Ultrasound Med. Biol. 2010, 36:1176-1187.
133. Park J., Fan Z., Deng C.X. Effects of shear stress cultivation on cell membrane disruption and intracellular calcium concentration in sonoporation of endothelial cells. J. Biomech. 2011, 44:164-169.
134. Ayata C., Shin H.K., Salomone S., Ozdemir-Gursoy Y., Boas D.A., Dunn A.K., Moskowitz M.A. Pronounced hypoperfusion during spreading depression in mouse cortex. J. Cereb. Blood Flow Metab. 2004, 24:1172-1182.
135. Burgess A., Huang Y., Querbes W., Sah D.W., Hynynen K. Focused ultrasound for targeted delivery of siRNA and efficient knockdown of Htt expression. J. Control. Release 2012, 163:125-129.
136. Choi J.J., Wang S., Tung Y.S., Morrison B., Konofagou E.E. Molecules of various pharmacologically-relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound Med. Biol. 2010, 36:58-67.
137. Muldoon L.L., Pagel M.A., Kroll R.A., Roman-Goldstein S., Jones R.S., Neuwelt E.A. A physiological barrier distal to the anatomic blood-brain barrier in a model of transvascular delivery. AJNR Am. J. Neuroradiol. 1999, 20:217-222.
138. Liu H.L., Hua M.Y., Chen P.Y., Chu P.C., Pan C.H., Yang H.W., Huang C.Y., Wang J.J., Yen T.C., Wei K.C. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 2010, 255:415-425.
139. Mei J., Cheng Y., Song Y., Yang Y., Wang F., Liu Y., Wang Z. Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound. J. Ultrasound Med. 2009, 28:871-880.
140. Zeng H.Q., Lu L., Wang F., Luo Y., Lou S.F. Focused ultrasound-induced blood-brain barrier disruption enhances the delivery of cytarabine to the rat brain. J. Chemother. 2012, 24:358-363.
141. Wei K.C., Chu P.C., Wang H.Y., Huang C.Y., Chen P.Y., Tsai H.C., Lu Y.J., Lee P.Y., Tseng I.C., Feng L.Y., Hsu P.W., Yen T.C., Liu H.L. Focused ultrasound-induced blood-brain barrier opening to enhance temozolomide delivery for glioblastoma treatment: a preclinical study. PLoS One 2013, 8:e58995.
142. Aryal M., Vykhodtseva N., Zhang Y.Z., Park J., McDannold N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J. Control. Release 2013, 169:103-111.
143. Yang F.Y., Wong T.T., Teng M.C., Liu R.S., Lu M., Liang H.F., Wei M.C. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme. J. Control. Release 2012, 160(3):652-658.
144. Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Wu J.S., Tseng I.C., Wang J.J., Yen T.C., Chen P.Y., Wei K.C. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:15205-15210.
145. Chen P.Y., Liu H.L., Hua M.Y., Yang H.W., Huang C.Y., Chu P.C., Lyu L.A., Tseng I.C., Feng L.Y., Tsai H.C., Chen S.M., Lu Y.J., Wang J.J., Yen T.C., Ma Y.H., Wu T., Chen J.P., Chuang J.I., Shin J.W., Hsueh C., Wei K.C. Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment. Neuro Oncol. 2010, 12:1050-1060.
146. Fan C.H., Ting C.Y., Lin H.J., Wang C.H., Liu H.L., Yen T.C., Yeh C.K. SPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug delivery. Biomaterials 2013, 34:3706-3715.
147. Kinoshita M., McDannold N., Jolesz F.A., Hynynen K. Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11719-11723.
148. Park E.J., Zhang Y.Z., Vykhodtseva N., McDannold N. Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J. Control. Release 2012, 10.1016/j.jconrel.2012.09.007.
149. Yang F.Y., Chen Y.W., Chou F.I., Yen S.H., Lin Y.L., Wong T.T. Boron neutron capture therapy for glioblastoma multiforme: enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound. Future Oncol. 2012, 8:1361-1369.
150. Alkins R.D., Brodersen P.M., Sodhi R.N., Hynynen K. Enhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasound. Neuro Oncol. 2013, 15(9):1225-1235.
151. Alkins R., Burgess A., Ganguly M., Francia G., Kerbel R., Wels W.S., Hynynen K. Focused ultrasound delivers targeted immune cells to metastatic brain tumors. Cancer Res. 2013, 73:1892-1899.
152. Ting C.Y., Fan C.H., Liu H.L., Huang C.Y., Hsieh H.Y., Yen T.C., Wei K.C., Yeh C.K. Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 2012, 33:704-712.
153. Wang F., Shi Y., Lu L., Liu L., Cai Y., Zheng H., Liu X., Yan F., Zou C., Sun C., Shi J., Lu S., Chen Y. Targeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound. PLoS One 2012, 7:e52925.
154. Huang Q., Deng J., Wang F., Chen S., Liu Y., Wang Z., Wang Z., Cheng Y. Targeted gene delivery to the mouse brain by MRI-guided focused ultrasound-induced blood-brain barrier disruption. Exp. Neurol. 2012, 233:350-356.
155. Fan C.H., Ting C.Y., Liu H.L., Huang C.Y., Hsieh H.Y., Yen T.C., Wei K.C., Yeh C.K. Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment. Biomaterials 2013, 34:2142-2155.
156. Baseri B., Choi J.J., Deffieux T., Samiotaki G., Tung Y.S., Olumolade O., Small S.A., Morrison B., Konofagou E.E. Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood-brain barrier using focused ultrasound and microbubbles. Phys. Med. Biol. 2012, 57:N65-N81.
157. Raymond S.B., Treat L.H., Dewey J.D., McDannold N., Hynynen K., Bacskai B.J. Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models. PLoS One 2008, 3:e2175.
158. Jordao J.F., Ayala-Grosso C.A., Markham K., Huang Y., Chopra R., McLaurin J., Hynynen K., Aubert I. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease. PLoS One 2010, 5:e10549.
159. Burgess A., Ayala-Grosso C.A., Ganguly M., Jordao J.F., Aubert I., Hynynen K. Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One 2011, 6:e27877.
160. Thevenot E., Jordao J.F., O'Reilly M.A., Markham K., Weng Y.Q., Foust K.D., Kaspar B.K., Hynynen K., Aubert I. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum. Gene Ther. 2012, 23:1144-1155.
161. Alonso A., Reinz E., Leuchs B., Kleinschmidt J., Fatar M., Geers B., Lentacker I., Hennerici M.G., de Smedt S.C., Meairs S. Focal delivery of AAV2/1-transgenes into the rat brain by localized ultrasound-induced BBB opening. Mol. Ther. Nucleic Acids 2013, 2:e73.
162. Hsu P.H., Wei K.C., Huang C.Y., Wen C.J., Yen T.C., Liu C.L., Lin Y.T., Chen J.C., Shen C.R., Liu H.L. Noninvasive and targeted gene delivery into the brain using microbubble-facilitated focused ultrasound. PLoS One 2013, 8:e57682.
163. Treat L.H., McDannold N., Zhang Y., Vykhodtseva N., Hynynen K. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med. Biol. 2012, 38:1716-1725.
164. Jordao J.F., Thevenot E., Markham-Coultes K., Scarcelli T., Weng Y.Q., Xhima K., O'Reilly M., Huang Y., McLaurin J., Hynynen K., Aubert I. Amyloid-beta plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound. Exp. Neurol. 2013, 248:16-29.
165. Choi J.J., Pernot M., Small S.A., Konofagou E.E. Noninvasive, transcranial and localized opening of the blood-brain barrier using focused ultrasound in mice. Ultrasound Med. Biol. 2007, 33:95-104.
166. O'Reilly M.A., Muller A., Hynynen K. Ultrasound insertion loss of rat parietal bone appears to be proportional to animal mass at submegahertz frequencies. Ultrasound Med. Biol. 2011, 37:1930-1937.
167. Pichardo S., Sin V.W., Hynynen K. Multi-frequency characterization of the speed of sound and attenuation coefficient for longitudinal transmission of freshly excised human skulls. Phys. Med. Biol. 2011, 56:219-250.
168. White P.J., Clement G.T., Hynynen K. Longitudinal and shear mode ultrasound propagation in human skull bone. Ultrasound Med. Biol. 2006, 32:1085-1096.
169. Hynynen K., Vykhodtseva N.I., Chung A.H., Sorrentino V., Colucci V., Jolesz F.A. Thermal effects of focused ultrasound on the brain: determination with MR imaging. Radiology 1997, 204:247-253.
170. McDannold N., Maier S.E. Magnetic resonance acoustic radiation force imaging. Med. Phys. 2008, 35:3748-3758.
171. Hosseinkhah N., Hynynen K. A three-dimensional model of an ultrasound contrast agent gas bubble and its mechanical effects on microvessels. Phys. Med. Biol. 2012, 57:785-808.
172. Tung Y.S., Marquet F., Teichert T., Ferrera V., Konofagou E.E. Feasibility of noninvasive cavitation-guided blood-brain barrier opening using focused ultrasound and microbubbles in nonhuman primates. Appl. Phys. Lett. 2011, 98:163704.
173. O'Reilly M.A., Hynynen K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 2012, 263:96-106.
174. Salgaonkar V.A., Datta S., Holland C.K., Mast T.D. Passive cavitation imaging with ultrasound arrays. J. Acoust. Soc. Am. 2009, 126:3071-3083.
175. Gyongy M., Coussios C.C. Passive cavitation mapping for localization and tracking of bubble dynamics. J. Acoust. Soc. Am. 2010, 128:EL175-EL180.
176. Arvanitis C.D., Livingstone M.S., McDannold N. Combined ultrasound and MR imaging to guide focused ultrasound therapies in the brain. Phys. Med. Biol. 2013, 58:4749-4761.
177. Yang F.Y., Wang H.E., Lin G.L., Teng M.C., Lin H.H., Wong T.T., Liu R.S. Micro-SPECT/CT-based pharmacokinetic analysis of 99mTc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasound. J. Nucl. Med. 2011, 52:478-484.
178. Yang F.Y., Horng S.C., Lin Y.S., Kao Y.H. Association between contrast-enhanced MR images and blood-brain barrier disruption following transcranial focused ultrasound. J. Magn. Reson. Imaging 2010, 32:593-599.
179. Chu P.C., Chai W.Y., Hsieh H.Y., Wang J.J., Wey S.P., Huang C.Y., Wei K.C., Liu H.L. Pharmacodynamic analysis of magnetic resonance imaging-monitored focused ultrasound-induced blood-brain barrier opening for drug delivery to brain tumors. Biomed. Res. Int. 2013, 2013:627496.
180. Vlachos F., Tung Y.S., Konofagou E.E. Permeability assessment of the focused ultrasound-induced blood-brain barrier opening using dynamic contrast-enhanced MRI. Phys. Med. Biol. 2010, 55:5451-5466.
181. Raymond S.B., Hynynen K. Acoustic transmission losses and field alterations due to human scalp hair. IEEE Trans. Ultrason. Ferroelectr. Freq. Control 2005, 52:1415-1419.
182. Park J., Zhang Y., Vykhodtseva N., Akula J.D., McDannold N.J. Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles. PLoS One 2012, 7:e42754.
183. Wachsmuth J., Chopra R., Hynynen K. Feasibility of transient image-guided blood-spinal cord barrier disruption. AIP Conf.Proc. 2008, 1113:256-259.
184. Fischer K., McDannold N.J., Zhang Y., Kardos M., Szabo A., Szabo A., Reusz G.S., Jolesz F.A. Renal ultrafiltration changes induced by focused US. Radiology 2009, 253:697-705.
185. McDannold N.J., Vykhodtseva N.I., Hynynen K. Microbubble contrast agent with focused ultrasound to create brain lesions at low power levels: MR imaging and histologic study in rabbits. Radiology 2006, 241:95-106.
186. Borrelli M.J., O'Brien W.D., Hamilton E., Oelze M.L., Wu J., Bernock L.J., Tung S., Rokadia H., Culp W.C. Influences of microbubble diameter and ultrasonic parameters on in vitro sonothrombolysis efficacy. J. Vasc. Interv. Radiol. 2012, 23:1677-1684.
187. Czarnota G.J., Karshafian R., Burns P.N., Wong S., Al Mahrouki A., Lee J.W., Caissie A., Tran W., Kim C., Furukawa M., Wong E., Giles A. Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E2033-E2041.
188. Yang F.Y., Fu W.M., Chen W.S., Yeh W.L., Lin W.L. Quantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruption. Ultrason. Sonochem. 2008, 15:636-643.
189. McDannold N., Vykhodtseva N., Hynynen K. Use of ultrasound pulses combined with Definity for targeted blood-brain barrier disruption: a feasibility study. Ultrasound Med. Biol. 2007, 33:584-590.
190. Lin K.J., Liu H.L., Hsu P.H., Chung Y.H., Huang W.C., Chen J.C., Wey S.P., Yen T.C., Hsiao I.T. Quantitative micro-SPECT/CT for detecting focused ultrasound-induced blood-brain barrier opening in the rat. Nucl. Med. Biol. 2009, 36:853-861.
191. Yang F.Y., Wang H.E., Lin G.L., Lin H.H., Wong T.T. Evaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasound. Int. J. Nanomedicine 2012, 7:723-730.
192. Huang Q., Deng J., Xie Z., Wang F., Chen S., Lei B., Liao P., Huang N., Wang Z., Wang Z., Cheng Y. Effective gene transfer into central nervous system following ultrasound-microbubbles-induced opening of the blood-brain barrier. Ultrasound Med. Biol. 2012, 38:1234-1243.
193. Etame A.B., Diaz R.J., O'Reilly M.A., Smith C.A., Mainprize T.G., Hynynen K., Rutka J.T. Enhanced delivery of gold nanoparticles with therapeutic potential into the brain using MRI-guided focused ultrasound. Nanomedicine 2012, 8(7):1133-1142.
194. Wang P.H., Liu H.L., Hsu P.H., Lin C.Y., Wang C.R., Chen P.Y., Wei K.C., Yen T.C., Li M.L. Gold-nanorod contrast-enhanced photoacoustic micro-imaging of focused-ultrasound induced blood-brain-barrier opening in a rat model. J. Biomed. Opt. 2012, 17:061222.